| Clinical spectrum of human STAR variants and their genotype–phenotype correlation EM Altinkilic, P Augsburger, AV Pandey, CE Flück Journal of Endocrinology 262 (3), 2024 | | 2024 |
| Insight into the role of TXNRD2 in steroidogenesis through a novel homozygous TXNRD2 splice variant C Brachet, A Laemmle, M Cools, KS Sauter, E De Baere, A Vanlander, ... European journal of endocrinology 191 (2), 144-155, 2024 | | 2024 |
| FDXR variants cause adrenal insufficiency and atypical sexual development E Pignatti, J Slone, MA Gomez-Cano, TM Campbell, J Vu, K Sauter, ... | | 2024 |
| Nanoencapsulation of Curcumin-Piperine Complex for Targeting CYP17A1 in Castration-Resistant Prostate Cancer A Pandey, J Yakubu, E Natsaridis, O Tagit, T du Toit Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations J Yakubu, AV Pandey Pharmaceutics 16 (5), 637, 2024 | 2 | 2024 |
| Nano‐Delivery Systems for Curcumin J Yakubu, AV Pandey Preprints, 2024 | | 2024 |
| A Novel Mutation in the INSR Gene Causes Severe Insulin Resistance and Rabson–Mendenhall Syndrome in a Paraguayan Patient MN Rojas Velazquez, F Blanco, A Ayala-Lugo, L Franco, V Jolly, ... International journal of molecular sciences 25 (6), 3143, 2024 | 2 | 2024 |
| Effect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450 K Sharma, A Lanzilotto, J Yakubu, S Therkelsen, CD Vöegel, T Du Toit, ... Biomolecules 14 (2), 203, 2024 | 3 | 2024 |
| Pharmacogenomics of poor drug metabolism in greyhounds: Canine P450 oxidoreductase genetic variation, breed heterogeneity, and functional characterization SE Martinez, AV Pandey, TE Perez Jimenez, Z Zhu, MH Court Plos one 19 (2), e0297191, 2024 | | 2024 |
| Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and … MN Rojas Velazquez, S Therkelsen, AV Pandey Biomolecules 13 (12), 1728, 2023 | 1 | 2023 |
| Essential Oil Components May Act as Antiandrogen Compounds in Prostate Cancer by Inhibition of Steroidogenic Cytochrome P450 Activities K Sharma, A Lanzilotto, J Yakubu, S Therkelsen, CD Voegel, T Du Toit, ... Preprints, 2023 | | 2023 |
| Exploring the potential of sulfur moieties in compounds inhibiting steroidogenesis TM Wróbel, K Sharma, I Mannella, S Oliaro-Bosso, P Nieckarz, T Du Toit, ... Biomolecules 13 (9), 1349, 2023 | 1 | 2023 |
| The Metabolism of 11-Oxy Androgens by Fetal CYP3A7 and CYP3A4 is Less Efficient Compared to Classical Androgens T du Toit, CE Fluck, AV Pandey, M Groessl HORMONE RESEARCH IN PAEDIATRICS 96, 264-264, 2023 | | 2023 |
| Expanding the p.(Arg85Trp) variant-specific phenotype of HNF4A: Features of glycogen storage disease, liver cirrhosis, impaired mitochondrial function, and glomerular changes M Grassi, B Laubscher, AV Pandey, S Tschumi, F Graber, A Schaller, ... Molecular syndromology 14 (4), 347-362, 2023 | 1 | 2023 |
| Targeting human melanocortin type 2 receptor (MC2R) with small molecules and designed peptides for the treatment of congenital adrenal hyperplasia A Pandey, S Parween, S Singh Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Analysis of novel variants in the Cytochrome P450 Oxidoreductase gene found in the Genome Aggregation Database applying Bioinformatics Tools and Functional assays MNR Velazquez, S Therkelsen, A Pandey Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Endocrine Disrupting Chemicals as" structural cues" for the development of drugs for the treatment of Prostate Cancer (Castration Resistant Prostate Cancer) and PCOS K Sharma, A Lanzilotto, S Therkelsen, T du Toit, FS Jørgensen, A Pandey Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Non-steroidal CYP17A1 inhibitors: discovery and assessment TM Wróbel, FS Jørgensen, AV Pandey, A Grudzińska, K Sharma, ... Journal of medicinal chemistry 66 (10), 6542-6566, 2023 | 18 | 2023 |
| Loss of LGR4/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation C Lucas, KS Sauter, M Steigert, D Mallet, J Wilmouth, J Olabe, I Plotton, ... The journal of clinical investigation 133 (4), 2023 | 7 | 2023 |
| Mutation V631I in the Cytochrome P450 oxidoreductase (POR) alters steroid biosynthesis and drug metabolism VMN Rojas, AV Pandey IMPE Abstracts 96, 2023 | | 2023 |
Christa E FluckUniversity Children's Hospital, Bern University, 3010 Bern, Switzerland在 unibe.ch 的电子邮件经过验证
